Blood glucose fluctuations in type 2 diabetes patients treated with multiple daily injections

• Main Authors: Li, F.-F, Fu, L.-Y, Zhang, W.-L, Su, X.-F, Wu, J.-D, Sun, J, Ye, L, Ma, J.-H
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: insulin aspart; insulin glargine; antidiabetic agent; biological marker; biphasic insulin; glucose blood level; insulin aspart, insulin aspart protamine drug combination 30:70; isophane insulin; adult; aged; Article; bedtime dosage; blood glucose monitoring; continuous subcutaneous insulin infusion; controlled study; drug dose reduction; drug dose titration; female; glycemic control; human; insulin intensive therapy; insulin treatment; intensive care; intermethod comparison; major clinical study; male; metabolic regulation; multicenter study; multiple daily injection; non insulin dependent diabetes mellitus; oxidative stress; priority journal; randomized controlled trial; therapy effect; treatment duration; treatment outcome; blood; China; clinical trial; comparative study; Diabetes Mellitus, Type 2; drug administration; drug effects; hospitalization; insulin infusion; metabolism; middle aged; pilot study; prospective study; subcutaneous drug administration; time factor; Adult; Aged; Biomarkers; Biphasic Insulins; Blood Glucose; Drug Administration Schedule; Female; Hospitalization; Humans; Hypoglycemic Agents; Infusions, Subcutaneous; Injections, Subcutaneous; Insulin Aspart; Insulin Glargine; Insulin Infusion Systems; Insulin, Isophane; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183727
• Institution: National University of Singapore

10.1155/2016/1028945